SMPD1 and aggressive systemic mastocytosis: Regarding treatment, the post hoc analysis revealed a trend of decreased Smpd1 mRNA expression in MDD Asm-tg amitriptyline-treated mice as compared with ASM-tg control mice (Sidak, p = 0.06).